Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia

被引：3
作者：
Asou, N [1 ]
机构：
[1] Kumamoto Univ, Dept Hematol, Sch Med, Kumamoto 8608556, Japan
来源：
INTERNAL MEDICINE | 2005年 / 44卷 / 08期
关键词：
acute promyelocytic leukemia; all-trans retinoic acid; arsenic trioxide; PML-RA alpha;
D O I：
10.2169/internalmedicine.44.775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 776
页数：2
相关论文
共 8 条
[1]   Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy [J].
Asou, N ;
Adachi, K ;
Tamura, J ;
Kanamaru, A ;
Kageyama, S ;
Hiraoka, A ;
Omoto, E ;
Akiyama, H ;
Tsubaki, K ;
Saito, K ;
Kuriyama, K ;
Oh, H ;
Kitano, K ;
Miyawaki, S ;
Takeyama, K ;
Yamada, O ;
Nishikawa, K ;
Takahashi, M ;
Matsuda, S ;
Ohtake, S ;
Suzushima, H ;
Emi, N ;
Ohno, R .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :78-85
[2]   Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients [J].
Niu, C ;
Yan, H ;
Yu, T ;
Sun, HP ;
Liu, JX ;
Li, XS ;
Wu, W ;
Zhang, FQ ;
Chen, Y ;
Zhou, L ;
Li, JM ;
Zeng, XY ;
Yang, RRO ;
Yuan, MM ;
Ren, MY ;
Gu, FY ;
Cao, Q ;
Gu, BW ;
Su, XY ;
Chen, GQ ;
Xiong, SM ;
Zhang, TD ;
Waxman, S ;
Wang, ZY ;
Chen, Z ;
Hu, J ;
Shen, ZX ;
Chen, SJ .
BLOOD, 1999, 94 (10) :3315-3324
[3]   Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring [J].
Ohnishi, K ;
Yoshida, H ;
Shigeno, K ;
Nakamura, S ;
Fujisawa, S ;
Naito, K ;
Shinjo, K ;
Fujita, Y ;
Matsui, H ;
Sahara, N ;
Takeshita, A ;
Satoh, H ;
Terada, H ;
Ohno, R .
LEUKEMIA, 2002, 16 (04) :617-622
[4]   Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate [J].
Ohno, R ;
Asou, N ;
Ohnishi, K .
LEUKEMIA, 2003, 17 (08) :1454-1463
[5]   Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE) .2. Clinical efficacy and pharmacokinetics in relapsed patients [J].
Shen, ZX ;
Chen, GQ ;
Ni, JH ;
Li, XS ;
Xiong, SM ;
Qiu, QY ;
Zhu, J ;
Tang, W ;
Sun, GL ;
Yang, KQ ;
Chen, Y ;
Zhou, L ;
Fang, ZW ;
Wang, YT ;
Ma, J ;
Zhang, P ;
Zhang, TD ;
Chen, SJ ;
Chen, Z ;
Wang, ZY .
BLOOD, 1997, 89 (09) :3354-3360
[6]   Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia:: A comparison to all-trans retinoic acid treatment [J].
Shinjo, K ;
Takeshita, A ;
Sahara, N ;
Kobayashi, M ;
Nakamura, S ;
Shigeno, K ;
Naito, K ;
Maekawa, M ;
Ohnishi, K ;
Ohno, R .
INTERNAL MEDICINE, 2005, 44 (08) :818-824
[7]   United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia [J].
Soignet, SL ;
Frankel, SR ;
Douer, D ;
Tallman, MS ;
Kantarjian, H ;
Calleja, E ;
Stone, RM ;
Kalaycio, M ;
Scheinberg, DA ;
Steinherz, P ;
Sievers, EL ;
Coutré, S ;
Dahlberg, S ;
Ellison, R ;
Warrell, RP .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) :3852-3860
[8]   Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide [J].
Soignet, SL ;
Maslak, P ;
Wang, ZG ;
Jhanwar, S ;
Calleja, E ;
Dardashti, LJ ;
Corso, D ;
DeBlasio, A ;
Gabrilove, J ;
Scheinberg, DA ;
Pandolfi, PP ;
Warrell, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (19) :1341-1348
1